サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1708043

糖尿病性足潰瘍治療薬の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）

Diabetic Foot Ulcer Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 190 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
糖尿病性足潰瘍治療薬の世界市場：業界分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年04月16日
発行: Persistence Market Research
ページ情報: 英文 190 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の糖尿病性足潰瘍治療薬の市場規模は、2025年に75億7,850万米ドルになるとみられ、2025年～2032年の予測期間に5.8%のCAGRで拡大し、2032年には112億4,680万米ドルに達すると予測されています。

糖尿病性足潰瘍（DFU）治療薬市場には、糖尿病患者の慢性創傷に関連する治癒の促進や合併症の予防を目的とした、さまざまな先進治療や機器が含まれます。DFUは糖尿病の最も深刻な合併症の一つであり、効果的な治療が行われないと感染症や切断に至ることも多いです。この市場には、高度創傷被覆材、代用皮膚、成長因子、陰圧創傷治療（NPWT）機器などのソリューションが含まれます。糖尿病有病率の上昇、創傷ケアに対する意識の高まり、技術的に進歩した治療薬に対する需要の高まりが、市場の成長を大きく後押ししています。

世界の糖尿病性足潰瘍治療薬市場は、世界の糖尿病有病率の上昇と糖尿病患者の足潰瘍発生率の上昇が主な要因となっています。特に創傷ケア管理におけるヘルスケア支出の増加と、代用皮膚やNPWTデバイスなどの創傷治癒技術の進歩が市場拡大に寄与しています。さらに、未治療の糖尿病性足潰瘍のリスクに関する意識の高まりや、専門医療センターの利用可能性の拡大が、診断率や治療率の上昇につながっています。新興国市場における有利な償還政策や、エビデンスに基づく治療プロトコルの採用増加も、市場の上昇を支えています。

大きな成長が見込まれますが、糖尿病性足潰瘍治療薬市場はいくつかの課題に直面しています。特に中低所得国では治療費が高いため、先進的な治療法への患者のアクセスが制限されています。さらに、発展途上地域における認識不足や、訓練を受けた創傷治療の専門家の不足が、タイムリーな診断と効果的な管理を妨げています。革新的な創傷治療製品の承認に関連する規制上のハードルが、新規参入企業の市場参入を遅らせています。さらに、患者が治療レジメンに従わなかったり、受診が遅れたりすると、治療成績に悪影響を及ぼす可能性があります。

糖尿病性足潰瘍治療薬市場は、創傷ケア研究への投資の増加、次世代バイオ人工皮膚や成長因子の開発により、有望な機会を秘めています。スマート創傷ケア機器やリアルタイムモニタリング用デジタルヘルスプラットフォームの出現は、患者中心のケアに新たなフロンティアを開きます。アジア太平洋、ラテンアメリカ、中東の未開拓市場は、糖尿病人口の増加とヘルスケアインフラの改善により、大きな成長の可能性を秘めています。医療機器企業とヘルスケアプロバイダーとの戦略的提携や、糖尿病ケアサービス強化に向けた政府の取り組みが、市場プレーヤーに有利な道をさらに切り開きます。

当レポートでは、世界の糖尿病性足潰瘍治療薬市場について調査し、製品タイプ別、潰瘍タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値のある洞察

第4章 価格分析、2025年

第5章 世界の糖尿病性足潰瘍治療薬市場の見通し

  • 主なハイライト
  • 市場規模分析と予測
    • 過去の市場規模（100万米ドル）分析、2019年～2024年
    • 現在の市場規模（100万米ドル）分析と予測、2025年～2032年
  • 世界の糖尿病性足潰瘍治療薬市場の見通し：製品タイプ別
    • イントロダクション/主な調査結果
    • 過去の市場規模（100万米ドル）と数量（個）分析、製品タイプ別、2019年～2024年
    • 現在の市場規模（100万米ドル）と数量（個）分析および予測、製品タイプ別、2025年～2032年
    • 市場の魅力分析：製品タイプ別
  • 世界の糖尿病性足潰瘍治療薬市場の見通し：潰瘍タイプ別
    • イントロダクション/主な調査結果
    • 過去の市場規模（100万米ドル）分析、潰瘍タイプ別、2019年～2024年
    • 現在の市場規模（100万米ドル）分析および予測、潰瘍タイプ別、2025年～2032年
    • 市場の魅力分析：潰瘍タイプ別
  • 世界の糖尿病性足潰瘍治療薬市場の見通し：エンドユーザー別
    • イントロダクション/主な調査結果
    • 過去の市場規模（100万米ドル）分析、エンドユーザー別、2019年～2024年
    • 現在の市場規模（100万米ドル）分析および予測、エンドユーザー別、2025年～2032年
    • 市場の魅力分析：エンドユーザー別

第6章 世界の糖尿病性足潰瘍治療薬市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模（100万米ドル）分析、地域別、2019年～2024年
  • 現在の市場規模（100万米ドル）分析および予測、地域別、2025年～2032年
    • 北米
    • 欧州
    • 東アジア
    • 南アジアとオセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第7章 北米の糖尿病性足潰瘍治療薬市場の見通し

第8章 欧州の糖尿病性足潰瘍治療薬市場の見通し

第9章 東アジアの糖尿病性足潰瘍治療薬市場の見通し

第10章 南アジアおよびオセアニアの糖尿病性足潰瘍治療薬市場の見通し

第11章 ラテンアメリカ糖尿病性足潰瘍治療薬市場の見通し

第12章 中東・アフリカの糖尿病性足潰瘍治療薬市場の見通し

第13章 競合情勢

  • 市場シェア分析、2025年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • ConvaTec Group Plc
    • B Braun Melsungen AG
    • Acelity LP Inc.
    • Molnlycke Health Care AB
    • 3M Health Care
    • Smith &Nephew Plc.
    • Coloplast Corp.
    • Medline Industries, LP
    • Medtronic Plc

第14章 付録

目次
Product Code: PMRREP5441

Persistence Market Research has recently released a comprehensive report on the global Diabetic Foot Ulcer Therapeutics Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Diabetic Foot Ulcer Therapeutics Market Size (2025E): US$ 7,578.5 Mn
  • Projected Market Value (2032F): US$ 11,246.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Diabetic Foot Ulcer Therapeutics Market - Report Scope:

The diabetic foot ulcer (DFU) therapeutics market encompasses a range of advanced treatments and devices aimed at promoting healing and preventing complications associated with chronic wounds in diabetic patients. DFUs are among the most severe complications of diabetes, often leading to infections and amputations if not treated effectively. The market includes solutions such as advanced wound dressings, skin substitutes, growth factors, and negative pressure wound therapy (NPWT) devices. Rising diabetes prevalence, increased awareness of wound care, and growing demand for technologically advanced therapeutics are significantly propelling market growth.

Market Growth Drivers:

The global diabetic foot ulcer therapeutics market is primarily driven by the growing global prevalence of diabetes and the rising incidence of foot ulcers among diabetic populations. Increased healthcare spending, particularly in wound care management, along with advancements in wound healing technologies such as skin substitutes and NPWT devices, are contributing to market expansion. Moreover, heightened awareness regarding the risks of untreated diabetic foot ulcers and the growing availability of specialized care centers have led to increased diagnosis and treatment rates. Favorable reimbursement policies in developed regions and the increasing adoption of evidence-based treatment protocols also support the market's upward trajectory.

Market Restraints:

Despite strong growth prospects, the diabetic foot ulcer therapeutics market faces several challenges. High treatment costs, especially in low- and middle-income countries, limit patient access to advanced therapies. In addition, lack of awareness in underdeveloped regions and the shortage of trained wound care specialists hinder timely diagnosis and effective management. Regulatory hurdles related to the approval of innovative wound care products can slow market entry for new players. Furthermore, patient non-compliance with treatment regimens and delayed medical attention can negatively impact therapeutic outcomes.

Market Opportunities:

The diabetic foot ulcer therapeutics market holds promising opportunities driven by increasing investments in wound care research and the development of next-generation bioengineered skin substitutes and growth factors. The emergence of smart wound care devices and digital health platforms for real-time monitoring opens new frontiers for patient-centric care. Untapped markets in Asia-Pacific, Latin America, and the Middle East present considerable growth potential due to the rising diabetic population and improving healthcare infrastructure. Strategic collaborations between medical device companies and healthcare providers, as well as government initiatives to enhance diabetic care services, further create lucrative avenues for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the global diabetic foot ulcer therapeutics market's growth?
  • Which regions and product segments are experiencing the highest demand for DFU treatment?
  • How are innovations in wound healing technologies influencing market dynamics?
  • Who are the key players in the diabetic foot ulcer therapeutics market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global DFU therapeutics market?

Competitive Intelligence and Business Strategy:

Leading companies in the global diabetic foot ulcer therapeutics market, such as ConvaTec Group Plc, B Braun Melsungen AG, and Smith & Nephew Plc, are investing heavily in product development, clinical trials, and strategic partnerships to expand their therapeutic portfolios. These companies focus on improving treatment efficacy, patient comfort, and wound healing time through advanced materials and biologics. Market leaders are also strengthening distribution channels and entering emerging economies to boost market penetration. Emphasis on personalized wound care solutions, along with regulatory approvals for new therapies, continues to shape the competitive landscape.

Companies Covered in This Report:

  • ConvaTec Group Plc
  • B Braun Melsungen AG
  • Acelity L.P. Inc.
  • Molnlycke Health Care AB
  • 3M Health Care
  • Smith & Nephew Plc.
  • Coloplast Corp.
  • Medline Industries, LP
  • Medtronic Plc

Market Segmentation

By Product Type:

  • Advanced Wound Dressings
  • Skin Substitutes
  • Negative Pressure Wound Therapy Devices
  • Growth Factors

By Ulcer Type:

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-Ischemic Ulcers

By End-user:

  • Hospitals
  • Specialty Clinics
  • Long-term Care Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Diabetic Foot Ulcer Therapeutics Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Price Analysis, 2025A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Type Prices
  • 4.3. Pricing Analysis, By Product Type
  • 4.4. Regional Prices and Product Type Preferences

5. Global Diabetic Foot Ulcer Therapeutics Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 5.3. Global Diabetic Foot Ulcer Therapeutics Market Outlook: Product Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product Type, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
      • 5.3.3.1. Advanced Wound Dressings
      • 5.3.3.2. Skin Substitutes
      • 5.3.3.3. Negative Pressure Wound Therapy Devices
      • 5.3.3.4. Growth Factors
    • 5.3.4. Market Attractiveness Analysis: Product Type
  • 5.4. Global Diabetic Foot Ulcer Therapeutics Market Outlook: Ulcer Type
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis, By Ulcer Type, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
      • 5.4.3.1. Neuropathic Ulcers
      • 5.4.3.2. Ischemic Ulcers
      • 5.4.3.3. Neuro-Ischemic Ulcers
    • 5.4.4. Market Attractiveness Analysis: Ulcer Type
  • 5.5. Global Diabetic Foot Ulcer Therapeutics Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Specialty Clinics
      • 5.5.3.3. Long-term Care Centers
      • 5.5.3.4. Ambulatory Surgical Centers
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Diabetic Foot Ulcer Therapeutics Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Diabetic Foot Ulcer Therapeutics Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Ulcer Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
    • 7.4.1. Advanced Wound Dressings
    • 7.4.2. Skin Substitutes
    • 7.4.3. Negative Pressure Wound Therapy Devices
    • 7.4.4. Growth Factors
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
    • 7.5.1. Neuropathic Ulcers
    • 7.5.2. Ischemic Ulcers
    • 7.5.3. Neuro-Ischemic Ulcers
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Long-term Care Centers
    • 7.6.4. Ambulatory Surgical Centers
  • 7.7. Market Attractiveness Analysis

8. Europe Diabetic Foot Ulcer Therapeutics Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Ulcer Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
    • 8.4.1. Advanced Wound Dressings
    • 8.4.2. Skin Substitutes
    • 8.4.3. Negative Pressure Wound Therapy Devices
    • 8.4.4. Growth Factors
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
    • 8.5.1. Neuropathic Ulcers
    • 8.5.2. Ischemic Ulcers
    • 8.5.3. Neuro-Ischemic Ulcers
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Long-term Care Centers
    • 8.6.4. Ambulatory Surgical Centers
  • 8.7. Market Attractiveness Analysis

9. East Asia Diabetic Foot Ulcer Therapeutics Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Ulcer Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
    • 9.4.1. Advanced Wound Dressings
    • 9.4.2. Skin Substitutes
    • 9.4.3. Negative Pressure Wound Therapy Devices
    • 9.4.4. Growth Factors
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
    • 9.5.1. Neuropathic Ulcers
    • 9.5.2. Ischemic Ulcers
    • 9.5.3. Neuro-Ischemic Ulcers
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Long-term Care Centers
    • 9.6.4. Ambulatory Surgical Centers
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Diabetic Foot Ulcer Therapeutics Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Ulcer Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
    • 10.4.1. Advanced Wound Dressings
    • 10.4.2. Skin Substitutes
    • 10.4.3. Negative Pressure Wound Therapy Devices
    • 10.4.4. Growth Factors
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
    • 10.5.1. Neuropathic Ulcers
    • 10.5.2. Ischemic Ulcers
    • 10.5.3. Neuro-Ischemic Ulcers
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Long-term Care Centers
    • 10.6.4. Ambulatory Surgical Centers
  • 10.7. Market Attractiveness Analysis

11. Latin America Diabetic Foot Ulcer Therapeutics Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Ulcer Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
    • 11.4.1. Advanced Wound Dressings
    • 11.4.2. Skin Substitutes
    • 11.4.3. Negative Pressure Wound Therapy Devices
    • 11.4.4. Growth Factors
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
    • 11.5.1. Neuropathic Ulcers
    • 11.5.2. Ischemic Ulcers
    • 11.5.3. Neuro-Ischemic Ulcers
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Long-term Care Centers
    • 11.6.4. Ambulatory Surgical Centers
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product Type
    • 12.2.3. By Ulcer Type
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product Type, 2025-2032
    • 12.4.1. Advanced Wound Dressings
    • 12.4.2. Skin Substitutes
    • 12.4.3. Negative Pressure Wound Therapy Devices
    • 12.4.4. Growth Factors
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Ulcer Type, 2025-2032
    • 12.5.1. Neuropathic Ulcers
    • 12.5.2. Ischemic Ulcers
    • 12.5.3. Neuro-Ischemic Ulcers
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Long-term Care Centers
    • 12.6.4. Ambulatory Surgical Centers
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. ConvaTec Group Plc
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. B Braun Melsungen AG
    • 13.3.3. Acelity L.P. Inc.
    • 13.3.4. Molnlycke Health Care AB
    • 13.3.5. 3M Health Care
    • 13.3.6. Smith & Nephew Plc.
    • 13.3.7. Coloplast Corp.
    • 13.3.8. Medline Industries, LP
    • 13.3.9. Medtronic Plc

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations